DR. AGARWAL’S HEALTH CARE LIMITED (MAINBOARD)
Jan 29, 2025 - Jan 31, 2025
| Price | ₹382 - ₹402 |
| Premium | ₹-4 |
|---|---|
| Lot size | 35 |
| Allotment | Feb 1, 2025 |
| Listing | Feb 4, 2025 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 35 | 14070 | 725960 |
| sHNI | 15 | 525 | 211050 | 6914 |
| bHNI | 72 | 2520 | 1013040 | 13828 |
Last updated on 31-Jan-2025 18:35:02
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 14519200 | 67361280 | 4.64 |
| HNIs | 10889400 | 4307310 | 0.4 |
| HNIs 10+ | 7259600 | 2285955 | 0.31 |
| HNIs 2+ | 3629800 | 2021355 | 0.56 |
| Retail | 25408599 | 10540285 | 0.41 |
| Employees | 1579399 | 425565 | 0.27 |
| Shareholders | 1129574 | 583940 | 0.52 |
| Total | 53526172 | 83218380 | 1.55 |
Application-Wise Breakup (Approx. no. of Apps) | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 13828 | 846 | 0.06 |
| HNIs (2-10L) | 6914 | 3432 | 0.5 |
| Retail | 725960 | 216584 | 0.3 |
| Shareholder | - | 6876 | - |
| Employee | - | 8343 | - |
| Subscription Demand (in ₹ crore) | |||
|---|---|---|---|
| Category | Offered | Demand | Times |
| QIBs | 583.67 | 2707.92 | 4.64 |
| FIIs | - | 2101.48 | - |
| DIIs | - | 130.92 | - |
| Mutual funds | - | 280 | - |
| Others | - | 195.52 | - |
| HNIs | 437.75 | 173.15 | 0.4 |
| HNIs 10+ | 291.84 | 91.9 | 0.31 |
| HNIs 2+ | 145.92 | 81.26 | 0.56 |
| Retail | 1021.43 | 423.72 | 0.41 |
| Employees | 63.49 | 17.11 | 0.27 |
| Shareholders | 45.41 | 23.47 | 0.52 |
| Total | 2151.75 | 3345.38 | 1.55 |
| QIB Interest Cost per share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹2.5 | @8% ₹2.9 | @9% ₹3.2 | @10% ₹3.6 | @11% ₹3.9 | @12% ₹4.3 |
IPO Details
| Total Issue Size | 7,53,04,970 Equity Shares aggregating up to 3027.26 crore. |
| Fresh Issue Size | 74,62,686 Equity Shares aggregating up to 300 crore. |
| Offer for Sale | 67,842,584 Equity Shares aggregating up to 2727.26 crore. |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE,BSE |
| Share holding pre issue | 308,417,160 Equity Shares |
| Share holding post issue | 31,58,79,846 Equity Shares |
IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Offer |
| Retail Shares Offered | Not less than 35% of the Net Offer |
| NII (HNI) Shares Offered | Not more than 15% of the Net Offer |
| Share Holder's Quata | 45.41 Cr |
Key Performance Indicators
| KPI | Sep-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE | 2.69% | 9.33% | 23.12% |
| ROCE | 8.30% | 14.61% | 15.18% |
| RONW | 1.90% | 6.21% | 14.99% |
| EPS (basic) | 1 | 3.13 | 4 |
| P/E Pre IPO | 130.44 | ||
| P/E Post IPO | 160.48 |
Financial Details In Crores
| Period Ended | Sep-24 | Mar-24 | Mar-23 | Mar-22 |
|---|---|---|---|---|
| Assets | 3,393 | 2,753 | 1,825 | 1,026 |
| Revenue | 838 | 1,376 | 1,031 | 714 |
| Profit After Tax | 40 | 95 | 103 | 43 |
| Net Worth | 1,503 | 1,338 | 628 | 212 |
| Reserves and Surplus | 1,509 | 1,366 | 653 | 236 |
| Total Borrowing | 374 | 388 | 356 | 290 |
About Company
Incorporated in 2010, Dr. Agarwal's Health Care Limited provides a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items. As of September 30, 2024, the company operated 193 facilities across 117 metro and non-metro cities in 14 states and four union territories in India, comprising 28 hubs (including three Centers of Excellence) and 165 spokes (53 Primary and 112 Secondary Facilities). The company employed 737 doctors, who served 2.13 million patients and performed 220,523 surgeries during the fiscal year, with 1.15 million patients treated and 140,787 surgeries conducted in the six months leading up to September 30, 2024. Its surgical offerings include cataract surgeries such as phacoemulsification and robotic cataract surgery; refractive surgeries like LASIK, SMILE, and PRK; and other procedures such as corneal transplantation, glaucoma treatment, and oculoplasty. The company's robust presence and diverse range of services position it as a leader in the Indian eye care sector.
Kotak Mahindra Capital Company Limited
Morgan Stanley India Company Private Limited
Jefferies India Private Limited
Motilal Oswal Investment Advisors Limited
Strong Brand Presence: Recognized as a leader in eye care services with an established brand and trust among patients.
Technological Advancements: Utilizes advanced technologies for precision and effective treatments.
Geographic Expansion: Wide network of hospitals in domestic and international markets.
High Competition: Operates in a competitive healthcare sector with pressure on pricing.
Regulatory Dependencies: Subject to stringent medical and financial regulations.
Operational Risks: Dependence on skilled personnel and risk of equipment obsolescence.
KFin Technologies Limited
Email: ahcl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/